Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x100px

Organisation › Details

Centers for Disease Control and Prevention (CDC) (US)

https://www.cdc.gov

	Start	1994-07-01 existent
	Group	United States (govt)
	Industry	HEALTH (HUMAN)

	City	n. a.
		Address record changed: 2020-12-02

Basic data	Employees	n. a.


		Record changed: 2023-07-10

Picture Berlin Partner Voices Robinson Data for Precision Medicine 650x200px

More documents for United States (govt)

[1] Bicycle Therapeutics plc. (1/4/23). "Press Release: Bicycle Therapeutics Announces FDA Fast Track Designation Granted to BT8009 for the Treatment of Adult Patients with Previously Treated Locally Advanced or Metastatic Urothelial Cancer". Cambridge & Bos...
[2] Adaptimmune Therapeutics plc. (11/8/22). "Press Release: Adaptimmune Reports Third-Quarter Financial Results and Business Update". Philadelphia, PA & Oxford....
[3] SwanBio Therapeutics, Inc.. (3/15/22). "Press Release: FDA Grants Orphan Drug Designation to SBT101, the First Investigational AAV-Based Gene Therapy for Adrenomyeloneuropathy (AMN)". Philadeliphia, PA....
[4] Immunocore Holdings plc. (1/26/22). "Press Release: Immunocore Announces FDA Approval of Kimmtrak (tebentafusp-tebn) for the Treatment of Unresectable or Metastatic Uveal Melanoma". Oxfordshire, Conshohocken, PA & Rockville, MD....
[5] Mobilion Systems, Inc.. (6/15/21). "Press Release: Mobilion Systems Launches MOBIE – the First SLIM-based High-Resolution Ion Mobility (HRIM) Product to Accelerate Biotherapeutic Drug Development and Multiomic Biomarker Discovery". Chadds Ford, PA....
[6] Gyroscope Therapeutics Ltd.. (3/26/21). "Press Release: Gyroscope Therapeutics Announces Additional Financing Plans". London....
[7] Inivata Ltd.. (3/9/21). "Press Release: FDA Grants Breakthrough Device Designation for Inivata’s RaDaR Assay". Research Triangle Park, NC & Cambridge....
[8] Immunocore Holdings plc. (2/19/21). "Press Release: Immunocore’s Tebentafusp Granted Breakthrough Therapy Designation for Unresectable or Metastatic Uveal Melanoma from FDA". Oxfordshire, Conshohocken, PA & Rockville, MD....
[9] ConserV Bioscience Ltd.. (1/19/21). "Press Release: ConserV Bioscience and Lawrence Livermore National Laboratory to Collaborate on Development of Broad-spectrum Coronavirus Vaccine". London & Livermore, CA....
[10] Merus N.V.. (1/7/21). "Press Release: Merus Granted FDA Fast Track Designation of Zenocutuzumab for the Treatment of Patients with Neuregulin 1 Fusion Cancers". Utrecht & Cambridge, MA....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)